ClinicalMetric / Countries / Finland / chronic kidney disease
← 🇫🇮 Finland Trials
🇫🇮 Finland Country × Condition

chronic kidney disease Clinical Trials in Finland

Active clinical trials for chronic kidney disease with research sites in Finland. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 3 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇫🇮 Finland

Active Trials in Finland (1)

NCT05970172 Phase 3
Recruiting

A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease

Enrollment
100 pts
Country
🇫🇮 Finland
Astellas Pharma Global Development,...
View Trial →

Frequently Asked Questions

How many chronic kidney disease clinical trials are active in Finland?
There are currently 1 active clinical trials for chronic kidney disease with sites in Finland, of which 1 are actively recruiting patients.
How can I join a chronic kidney disease clinical trial in Finland?
To join a chronic kidney disease clinical trial in Finland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Finland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are chronic kidney disease trials in Finland?
Active chronic kidney disease trials in Finland span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Finland Trials → Global chronic kidney disease Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology